APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Neuroscience

neurological disorders and the essence of human/animal behaviors and cognition. The key question of neuroscience is, as a branch of biology, to understand human neural activities, including learning, memory, attention, awareness, language, thinking and decision making, etc. As a branch of medicine, neuroscience addresses basic issues underlying neuropsychiatric disorders and interventions.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

neurological disorders and the essence of human/animal behaviors and cognition. The key question of neuroscience is, as a branch of biology, to understand human neural activities, including learning, memory, attention, awareness, language, thinking and decision making, etc. As a branch of medicine, neuroscience addresses basic issues underlying neuropsychiatric disorders and interventions.

Selected research

Market Outlook & Growth Opportunities

Global Neuroscience Market Outlook and Growth Opportunities 2026

Report ID 173894970431 December 2025197 pages

Choose your research edition.

Industry ResearchNeuroscience Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Neuroscience Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Neuroscience Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neuroscience Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Neuroscience Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

neurological disorders and the essence of human/animal behaviors and cognition. The key question of neuroscience is, as a branch of biology, to understand human neural activities, including learning, memory, attention, awareness, language, thinking and decision making, etc. As a branch of medicine, neuroscience addresses basic issues underlying neuropsychiatric disorders and interventions.

Global neuroscience main manufactuers include Siemens Healthineers, GE Healthcare, etc. The top 3 companies hold a share about 17%. Americas is the largest market of neuroscience, with a share about 40%, followed by Europe and Asia-Pacific.

This report provides an overview of the global Neuroscience market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Neuroscience and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Neuroscience revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Neuroscience market.

Neuroscience Segment by Company

Siemens Healthineers

GE Healthcare

Philips

Canon

Hitachi

Medtronic

Leica Microsystems

Zeiss

Nikon

JEOL Ltd

Natus Medical

Nihon Kohden

NeuroPace Inc

Shimadzu Corporation

Compumedics

Neuroscience Segment by Type

Instrument and Consumables

Software

Services

Neuroscience Segment by Application

Academic Institutes

Hospital

Research Institutes

Others

Neuroscience Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Neuroscience status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Neuroscience key companies, revenue, market share, and recent developments.

3. To split the Neuroscience breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Neuroscience market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Neuroscience significant trends, drivers, influence factors in global and regions.

6. To analyze Neuroscience competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neuroscience market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neuroscience and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neuroscience.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Neuroscience industry.

Chapter 3: Detailed analysis of Neuroscience company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Neuroscience in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Neuroscience in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Neuroscience Industry Trends Table 2. Neuroscience Industry Drivers Table 3. Neuroscience Industry Opportunities and Challenges Table 4. Neuroscience Industry Restraints Table 5. Global Neuroscience Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Neuroscience Revenue Share by Company (2021-2026) Table 7. Global Neuroscience Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Neuroscience Key Company Manufacturing Base & Headquarters Table 9. Global Neuroscience Company, Product Type & Application Table 10. Global Neuroscience Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Neuroscience by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Instrument and Consumables Table 15. Significant Companies of Software Table 16. Significant Companies of Services Table 17. Global Neuroscience Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Neuroscience Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Neuroscience Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Neuroscience Sales Value Share by Type (2021-2026) Table 21. Global Neuroscience Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Academic Institutes Table 23. Significant Companies of Hospital Table 24. Significant Companies of Research Institutes Table 25. Significant Companies of Others Table 26. Global Neuroscience Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Neuroscience Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Neuroscience Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Neuroscience Sales Value Share by Application (2021-2026) Table 30. Global Neuroscience Sales Value Share by Application (2027-2032) Table 31. Global Neuroscience Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Neuroscience Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Neuroscience Sales Value Share by Region (2021-2026) Table 34. Global Neuroscience Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Neuroscience Sales Value Share by Region (2027-2032) Table 36. Global Neuroscience Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Neuroscience Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Neuroscience Sales Value Market Share by Country (2021-2026) Table 39. Global Neuroscience Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Neuroscience Sales Value Market Share by Country (2027-2032) Table 41. Siemens Healthineers Company Information Table 42. Siemens Healthineers Business Overview Table 43. Siemens Healthineers Neuroscience Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Siemens Healthineers Neuroscience Product Portfolio Table 45. Siemens Healthineers Recent Development Table 46. GE Healthcare Company Information Table 47. GE Healthcare Business Overview Table 48. GE Healthcare Neuroscience Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. GE Healthcare Neuroscience Product Portfolio Table 50. GE Healthcare Recent Development Table 51. Philips Company Information Table 52. Philips Business Overview Table 53. Philips Neuroscience Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Philips Neuroscience Product Portfolio Table 55. Philips Recent Development Table 56. Canon Company Information Table 57. Canon Business Overview Table 58. Canon Neuroscience Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Canon Neuroscience Product Portfolio Table 60. Canon Recent Development Table 61. Hitachi Company Information Table 62. Hitachi Business Overview Table 63. Hitachi Neuroscience Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Hitachi Neuroscience Product Portfolio Table 65. Hitachi Recent Development Table 66. Medtronic Company Information Table 67. Medtronic Business Overview Table 68. Medtronic Neuroscience Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Medtronic Neuroscience Product Portfolio Table 70. Medtronic Recent Development Table 71. Leica Microsystems Company Information Table 72. Leica Microsystems Business Overview Table 73. Leica Microsystems Neuroscience Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Leica Microsystems Neuroscience Product Portfolio Table 75. Leica Microsystems Recent Development Table 76. Zeiss Company Information Table 77. Zeiss Business Overview Table 78. Zeiss Neuroscience Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Zeiss Neuroscience Product Portfolio Table 80. Zeiss Recent Development Table 81. Nikon Company Information Table 82. Nikon Business Overview Table 83. Nikon Neuroscience Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Nikon Neuroscience Product Portfolio Table 85. Nikon Recent Development Table 86. JEOL Ltd Company Information Table 87. JEOL Ltd Business Overview Table 88. JEOL Ltd Neuroscience Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. JEOL Ltd Neuroscience Product Portfolio Table 90. JEOL Ltd Recent Development Table 91. Natus Medical Company Information Table 92. Natus Medical Business Overview Table 93. Natus Medical Neuroscience Sales (Units), Value (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 94. Natus Medical Neuroscience Product Portfolio Table 95. Natus Medical Recent Development Table 96. Nihon Kohden Company Information Table 97. Nihon Kohden Business Overview Table 98. Nihon Kohden Neuroscience Sales (Units), Value (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 99. Nihon Kohden Neuroscience Product Portfolio Table 100. Nihon Kohden Recent Development Table 101. NeuroPace Inc Company Information Table 102. NeuroPace Inc Business Overview Table 103. NeuroPace Inc Neuroscience Sales (Units), Value (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 104. NeuroPace Inc Neuroscience Product Portfolio Table 105. NeuroPace Inc Recent Development Table 106. Shimadzu Corporation Company Information Table 107. Shimadzu Corporation Business Overview Table 108. Shimadzu Corporation Neuroscience Sales (Units), Value (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 109. Shimadzu Corporation Neuroscience Product Portfolio Table 110. Shimadzu Corporation Recent Development Table 111. Compumedics Company Information Table 112. Compumedics Business Overview Table 113. Compumedics Neuroscience Sales (Units), Value (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 114. Compumedics Neuroscience Product Portfolio Table 115. Compumedics Recent Development Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. Neuroscience Product Image Figure 2. Global Neuroscience Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neuroscience Market Size (2021-2032) & (US$ Million) Figure 4. Global Neuroscience Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Instrument and Consumables Image Figure 8. Software Image Figure 9. Services Image Figure 10. Global Neuroscience Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Neuroscience Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Neuroscience Sales Value Share by Type (2021-2032) Figure 13. Academic Institutes Image Figure 14. Hospital Image Figure 15. Research Institutes Image Figure 16. Others Image Figure 17. Global Neuroscience Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Neuroscience Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Neuroscience Sales Value Share by Application (2021-2032) Figure 20. Global Neuroscience Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Neuroscience Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Neuroscience Sales Value (2021-2032) & (US$ Million) Figure 23. North America Neuroscience Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Neuroscience Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Neuroscience Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Neuroscience Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Neuroscience Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Neuroscience Sales Value (2021-2032) & (US$ Million) Figure 29. South America Neuroscience Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Neuroscience Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Neuroscience Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Neuroscience Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Neuroscience Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Neuroscience Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Neuroscience Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Neuroscience Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Neuroscience Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Neuroscience Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Neuroscience Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Neuroscience Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Neuroscience Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Neuroscience Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Neuroscience Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Neuroscience Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Neuroscience Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Neuroscience Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Neuroscience Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Neuroscience Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Neuroscience Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Neuroscience Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Neuroscience Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Neuroscience Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Neuroscience Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Neuroscience Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Neuroscience Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Neuroscience Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Neuroscience Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Neuroscience Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Neuroscience Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Neuroscience Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Neuroscience Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Neuroscience Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Neuroscience Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Neuroscience Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Neuroscience Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Neuroscience Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Neuroscience Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Neuroscience Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Neuroscience Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Neuroscience Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Neuroscience Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Neuroscience Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Neuroscience Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Neuroscience Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Neuroscience Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Neuroscience Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Neuroscience Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Neuroscience Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Neuroscience Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Neuroscience Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Neuroscience Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Neuroscience Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Neuroscience Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Neuroscience Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Neuroscience Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Neuroscience Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Neuroscience Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Neuroscience Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Neuroscience Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Neuroscience Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Neuroscience Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Neuroscience Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Neuroscience Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Neuroscience Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Neuroscience Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Neuroscience Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Neuroscience Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Neuroscience Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Neuroscience Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Neuroscience Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Neuroscience Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Neuroscience Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Neuroscience Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Neuroscience Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Neuroscience Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Neuroscience Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Neuroscience Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Neuroscience Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Neuroscience Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Neuroscience Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Neuroscience Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Neuroscience Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Neuroscience Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Neuroscience Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Neuroscience Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Instrument and Consumables
  • Software
  • Services
Applications
  • Academic Institutes
  • Hospital
  • Research Institutes
  • Others
Companies covered
  • Siemens Healthineers
  • GE Healthcare
  • Philips
  • Canon
  • Hitachi
  • Medtronic
  • Leica Microsystems
  • Zeiss
  • Nikon
  • JEOL Ltd
  • Natus Medical
  • Nihon Kohden
  • NeuroPace Inc
  • Shimadzu Corporation
  • Compumedics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Neuroscience Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Neuroscience Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Neuroscience Market Dynamics
  1. 2.1 Neuroscience Industry Trends
  2. 2.2 Neuroscience Industry Drivers
  3. 2.3 Neuroscience Industry Opportunities and Challenges
  4. 2.4 Neuroscience Industry Restraints
3 Neuroscience Market by Company
  1. 3.1 Global Neuroscience Company Revenue Ranking in 2025
  2. 3.2 Global Neuroscience Revenue by Company (2021-2026)
  3. 3.3 Global Neuroscience Company Ranking (2024-2026)
  4. 3.4 Global Neuroscience Company Manufacturing Base and Headquarters
  5. 3.5 Global Neuroscience Company Product Type and Application
  6. 3.6 Global Neuroscience Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Neuroscience Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Neuroscience Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Neuroscience Market by Type
  1. 4.1 Neuroscience Type Introduction
  2. 4.1.1 Instrument and Consumables
  3. 4.1.2 Software
  4. 4.1.3 Services
  5. 4.2 Global Neuroscience Sales Value by Type
  6. 4.2.1 Global Neuroscience Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Neuroscience Sales Value by Type (2021-2032)
  8. 4.2.3 Global Neuroscience Sales Value Share by Type (2021-2032)
5 Neuroscience Market by Application
  1. 5.1 Neuroscience Application Introduction
  2. 5.1.1 Academic Institutes
  3. 5.1.2 Hospital
  4. 5.1.3 Research Institutes
  5. 5.1.4 Others
  6. 5.2 Global Neuroscience Sales Value by Application
  7. 5.2.1 Global Neuroscience Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Neuroscience Sales Value by Application (2021-2032)
  9. 5.2.3 Global Neuroscience Sales Value Share by Application (2021-2032)
6 Neuroscience Regional Value Analysis
  1. 6.1 Global Neuroscience Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Neuroscience Sales Value by Region (2021-2032)
  3. 6.2.1 Global Neuroscience Sales Value by Region: 2021-2026
  4. 6.2.2 Global Neuroscience Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Neuroscience Sales Value (2021-2032)
  7. 6.3.2 North America Neuroscience Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Neuroscience Sales Value (2021-2032)
  10. 6.4.2 Europe Neuroscience Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Neuroscience Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Neuroscience Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Neuroscience Sales Value (2021-2032)
  16. 6.6.2 South America Neuroscience Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Neuroscience Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Neuroscience Sales Value Share by Country, 2025 VS 2032
7 Neuroscience Country-level Value Analysis
  1. 7.1 Global Neuroscience Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Neuroscience Sales Value by Country (2021-2032)
  3. 7.2.1 Global Neuroscience Sales Value by Country (2021-2026)
  4. 7.2.2 Global Neuroscience Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Neuroscience Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Neuroscience Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Neuroscience Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Neuroscience Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Neuroscience Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Neuroscience Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Neuroscience Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Neuroscience Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Neuroscience Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Neuroscience Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Neuroscience Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Neuroscience Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Neuroscience Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Neuroscience Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Neuroscience Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Neuroscience Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Neuroscience Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Neuroscience Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Neuroscience Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Neuroscience Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Neuroscience Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Neuroscience Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Neuroscience Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Neuroscience Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Neuroscience Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Neuroscience Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Neuroscience Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Neuroscience Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Neuroscience Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Neuroscience Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Neuroscience Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Neuroscience Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Neuroscience Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Neuroscience Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Neuroscience Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Neuroscience Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Neuroscience Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Neuroscience Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Neuroscience Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Neuroscience Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Neuroscience Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Neuroscience Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Neuroscience Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Neuroscience Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Neuroscience Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Neuroscience Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Neuroscience Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Neuroscience Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Neuroscience Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Neuroscience Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Neuroscience Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Neuroscience Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Neuroscience Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Neuroscience Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Neuroscience Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Neuroscience Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Neuroscience Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Neuroscience Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Neuroscience Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Neuroscience Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Neuroscience Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Neuroscience Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Neuroscience Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Neuroscience Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Neuroscience Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Neuroscience Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Neuroscience Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Neuroscience Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Neuroscience Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Neuroscience Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Neuroscience Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Neuroscience Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Neuroscience Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Neuroscience Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Neuroscience Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Neuroscience Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Neuroscience Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Neuroscience Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Neuroscience Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Neuroscience Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Neuroscience Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Neuroscience Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Neuroscience Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Neuroscience Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Siemens Healthineers
  2. 8.1.1 Siemens Healthineers Company Information
  3. 8.1.2 Siemens Healthineers Business Overview
  4. 8.1.3 Siemens Healthineers Neuroscience Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Siemens Healthineers Neuroscience Product Portfolio
  6. 8.1.5 Siemens Healthineers Recent Developments
  7. 8.2 GE Healthcare
  8. 8.2.1 GE Healthcare Company Information
  9. 8.2.2 GE Healthcare Business Overview
  10. 8.2.3 GE Healthcare Neuroscience Revenue and Gross Margin (2021-2026)
  11. 8.2.4 GE Healthcare Neuroscience Product Portfolio
  12. 8.2.5 GE Healthcare Recent Developments
  13. 8.3 Philips
  14. 8.3.1 Philips Company Information
  15. 8.3.2 Philips Business Overview
  16. 8.3.3 Philips Neuroscience Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Philips Neuroscience Product Portfolio
  18. 8.3.5 Philips Recent Developments
  19. 8.4 Canon
  20. 8.4.1 Canon Company Information
  21. 8.4.2 Canon Business Overview
  22. 8.4.3 Canon Neuroscience Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Canon Neuroscience Product Portfolio
  24. 8.4.5 Canon Recent Developments
  25. 8.5 Hitachi
  26. 8.5.1 Hitachi Company Information
  27. 8.5.2 Hitachi Business Overview
  28. 8.5.3 Hitachi Neuroscience Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Hitachi Neuroscience Product Portfolio
  30. 8.5.5 Hitachi Recent Developments
  31. 8.6 Medtronic
  32. 8.6.1 Medtronic Company Information
  33. 8.6.2 Medtronic Business Overview
  34. 8.6.3 Medtronic Neuroscience Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Medtronic Neuroscience Product Portfolio
  36. 8.6.5 Medtronic Recent Developments
  37. 8.7 Leica Microsystems
  38. 8.7.1 Leica Microsystems Company Information
  39. 8.7.2 Leica Microsystems Business Overview
  40. 8.7.3 Leica Microsystems Neuroscience Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Leica Microsystems Neuroscience Product Portfolio
  42. 8.7.5 Leica Microsystems Recent Developments
  43. 8.8 Zeiss
  44. 8.8.1 Zeiss Company Information
  45. 8.8.2 Zeiss Business Overview
  46. 8.8.3 Zeiss Neuroscience Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Zeiss Neuroscience Product Portfolio
  48. 8.8.5 Zeiss Recent Developments
  49. 8.9 Nikon
  50. 8.9.1 Nikon Company Information
  51. 8.9.2 Nikon Business Overview
  52. 8.9.3 Nikon Neuroscience Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Nikon Neuroscience Product Portfolio
  54. 8.9.5 Nikon Recent Developments
  55. 8.10 JEOL Ltd
  56. 8.10.1 JEOL Ltd Company Information
  57. 8.10.2 JEOL Ltd Business Overview
  58. 8.10.3 JEOL Ltd Neuroscience Revenue and Gross Margin (2021-2026)
  59. 8.10.4 JEOL Ltd Neuroscience Product Portfolio
  60. 8.10.5 JEOL Ltd Recent Developments
  61. 8.11 Natus Medical
  62. 8.11.1 Natus Medical Company Information
  63. 8.11.2 Natus Medical Business Overview
  64. 8.11.3 Natus Medical Neuroscience Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Natus Medical Neuroscience Product Portfolio
  66. 8.11.5 Natus Medical Recent Developments
  67. 8.12 Nihon Kohden
  68. 8.12.1 Nihon Kohden Company Information
  69. 8.12.2 Nihon Kohden Business Overview
  70. 8.12.3 Nihon Kohden Neuroscience Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Nihon Kohden Neuroscience Product Portfolio
  72. 8.12.5 Nihon Kohden Recent Developments
  73. 8.13 NeuroPace Inc
  74. 8.13.1 NeuroPace Inc Company Information
  75. 8.13.2 NeuroPace Inc Business Overview
  76. 8.13.3 NeuroPace Inc Neuroscience Revenue and Gross Margin (2021-2026)
  77. 8.13.4 NeuroPace Inc Neuroscience Product Portfolio
  78. 8.13.5 NeuroPace Inc Recent Developments
  79. 8.14 Shimadzu Corporation
  80. 8.14.1 Shimadzu Corporation Company Information
  81. 8.14.2 Shimadzu Corporation Business Overview
  82. 8.14.3 Shimadzu Corporation Neuroscience Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Shimadzu Corporation Neuroscience Product Portfolio
  84. 8.14.5 Shimadzu Corporation Recent Developments
  85. 8.15 Compumedics
  86. 8.15.1 Compumedics Company Information
  87. 8.15.2 Compumedics Business Overview
  88. 8.15.3 Compumedics Neuroscience Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Compumedics Neuroscience Product Portfolio
  90. 8.15.5 Compumedics Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst